Home › Body Weight › NCT07442864

Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement

Evaluation of Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement Over 12 Weeks

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Adults aged 18 years or older
* Willing to pay for study supplies and able to take the dietary supplement daily for 12 weeks
* Willing to complete electronic questionnaires and self-reported measurements
* Able to provide informed consent

Exclusion Criteria:

* Pregnant or breastfeeding individuals
* Known allergy or sensitivity to any supplement ingredients
* Use of medications or supplements that could interfere with appetite or weight without medical clearance
* Any medical condition that would make participation unsafe, as determined by the participant

About the study

This study evaluates changes in hunger perception and body composition-related measures following daily use of a commercially available dietary supplement formulated to support leptin-related metabolic signaling. Adult participants will self-administer the supplement for 12 weeks and complete periodic self-reported assessments related to appetite, hunger, and weight-related outcomes. Participants serve as their own control, with comparisons made between baseline and follow-up measurements. The study is designed to generate preliminary, real-world evidence regarding supplement use in a general wellness context.

What is being tested

• Leptin Balance Formula (dietary supplement)

Sponsor: Efforia, Inc · Participants: 100 · Started: Sep 10, 2025

Contact the study team

• Matthew Amsden · Phone: 646-679-2479

Official record on ClinicalTrials.gov — NCT07442864

Locations in the U.S.

Conditions

• Body Weight

From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.